Genfit SA (GNFT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The companys pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program for auto-immune and inflammatory diseases; and TGFTX4 for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, liver diseases, non-alcoholic steatohepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. The companys research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA (GNFT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9
Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genfit SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genfit Enters into Agreement with Pinnacle Clinical Research Center 11
ImaBiotech Enters Into Agreement With Genfit 12
Equity Offering 13
Genfit Raises USD50 Million in Rights Offering of Shares 13
Genfit Raises USD38 Million Private Placement of Shares 14
Genfit Raises USD54.2 Million in Private Placement of Shares 15
Genfit Raises USD26 Million in Private Placement of Shares 16
Genfit Raises USD67.5 Million in Private Placement of Shares 17
Genfit Raises USD6.8 Million in Private Placement of Shares 18
Genfit Completes Private Placement Of Shares For US$19 Million 19
Debt Offering 20
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20
Acquisition 21
Novartis May Acquire Genfit 21
Genfit SA - Key Competitors 22
Genfit SA - Key Employees 23
Genfit SA - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Apr 27, 2018: GENFIT: First quarter 2018 financial information 25
Oct 11, 2017: GENFIT: Third quarter 2017 financial information 26
Sep 25, 2017: Genfit: 2017 Half-Year Results: Cash Position At End Of Period At 126M And Significant Advances In The CompanyS Pipeline 27
Apr 24, 2017: Genfit: Q1 2017 Financial Information 32
Government and Public Interest 36
Apr 10, 2018: Vanderbilt scientists test potential new way to treat anemia 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables

List of Tables
Genfit SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9
Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genfit Enters into Agreement with Pinnacle Clinical Research Center 11
ImaBiotech Enters Into Agreement With Genfit 12
Genfit Raises USD50 Million in Rights Offering of Shares 13
Genfit Raises USD38 Million Private Placement of Shares 14
Genfit Raises USD54.2 Million in Private Placement of Shares 15
Genfit Raises USD26 Million in Private Placement of Shares 16
Genfit Raises USD67.5 Million in Private Placement of Shares 17
Genfit Raises USD6.8 Million in Private Placement of Shares 18
Genfit Completes Private Placement Of Shares For US$19 Million 19
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20
Novartis May Acquire Genfit 21
Genfit SA, Key Competitors 22
Genfit SA, Key Employees 23
Genfit SA, Subsidiaries 24

List Of Figures

List of Figures
Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9

Genfit SA (GNFT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The companys pipeline products include GFT505, biomarkers,

USD 250 View Report

Genfit SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Genfit SA Company Profile is a detailed strategic and analytical report on Genfit SA. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Genfit SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Genfit SA Company Profile is a detailed strategic and analytical report on Genfit SA. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Genfit SA Strategic Analysis Review- Genfit SA SWOT, Outlook, Operations and Financial Profile

Genfit SA Company Profile provides strategic analysis of Genfit SA Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available